<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Facial nerve palsy in children</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Facial nerve palsy in children</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Facial nerve palsy in children</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Craig Zaidman, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Douglas R Nordli, Jr, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard P Goddeau, Jr, DO, FAHA</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 06, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Facial nerve palsy is a common malady in children that may be congenital or acquired. The underlying etiology often remains unclear despite extensive investigation.</p><p>In 1830, Sir Charles Bell first described unilateral facial weakness secondary to facial nerve dysfunction. His description of acquired, idiopathic facial paralysis is often termed Bell's palsy [<a href="#rid1">1</a>]. This topic will review clinical aspects of facial nerve palsy in children.</p><p>The clinical features and management of Bell's palsy in adults is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/5281.html" rel="external">"Bell's palsy: Pathogenesis, clinical features, and diagnosis in adults"</a> and  <a class="medical medical_review" href="/d/html/5286.html" rel="external">"Bell's palsy: Treatment and prognosis in adults"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">FACIAL NERVE ANATOMY</span><span class="headingEndMark"> — </span>The facial nerve has a complex anatomy and function that render it susceptible to multiple neurologic disorders based upon the location of the lesion  (<a class="graphic graphic_figure graphicRef138653" href="/d/graphic/138653.html" rel="external">figure 1</a>). Cranial nerve VII originates from multiple brainstem nuclei that are functionally specialized [<a href="#rid2">2,3</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>The motor component of VII, which accounts for movement of the facial musculature, arises from the motor nucleus of VII in the pontine tegmentum. Fibers innervating the forehead receive bilateral input via the corticobulbar tract, whereas the contralateral corticobulbar tract innervates the remaining facial muscles.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The superior salivatory nucleus is the origin of preganglionic parasympathetic fibers that innervate the lacrimal, sublingual, and submandibular glands. Innervating fibers of the submandibular and sublingual gland travel via the chorda tympani nerve, whereas the lacrimal gland fibers travel through the greater petrosal nerve.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Taste for the anterior two-thirds of the tongue and sensory fibers from the external acoustic canal travel to the solitary tract nucleus.</p><p></p><p>The fibers of the facial nerve emerge from the ventrolateral aspect of the brainstem at the caudal border of the pons and enter the petrous portion of the temporal bone via the internal auditory canal. The sensory fibers travel as the nervus intermedius portion of cranial nerve VII and run between cranial nerve VIII and the motor component of cranial nerve VII. In the temporal bone, the greater petrosal nerve arises from the labyrinthine segment of the facial nerve and carries preganglionic parasympathetic fibers to the pterygopalatine ganglion. The nerve then synapses and sends fibers to the lacrimal gland; lesions affecting the facial nerve prior to the greater petrosal nerve may cause decreased lacrimation. The facial nerve then courses along the medial wall of the anterior epitympanic recess; it is here that the facial nerve may be affected by cholesteatomas.</p><p>The mastoid segment of the facial nerve courses inferiorly, lateral to the jugular fossa, allowing lesions there to affect the facial nerve. The stapedius nerve arises from this segment and innervates the stapedius muscle. Lesions of the facial nerve prior to the stapedius nerve result in hyperacusis.</p><p>The chorda tympani arises distally in the mastoid segment and enters the middle ear via the canaliculus chordae tympani. It exits via the petrotympanic fissure and supplies afferent fibers for taste to the anterior two-thirds of the tongue. It also provides efferent parasympathetic fibers to the submandibular and sublingual glands that synapse in the submandibular ganglion. The facial nerve exits the skull via the stylomastoid foramen and courses through the parotid gland to divide and supply the muscles of facial expression.</p><p class="headingAnchor" id="H3"><span class="h1">ETIOLOGY AND EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>The possible causes of facial nerve palsy are many and may be congenital, infectious, neoplastic, traumatic, or idiopathic  (<a class="graphic graphic_table graphicRef76593" href="/d/graphic/76593.html" rel="external">table 1</a>) [<a href="#rid4">4,5</a>]. Approximately one-half of all cases qualify for the label "Bell's palsy," previously defined as an acute facial nerve palsy of unknown cause. An estimated 20 per 100,000 people per year are affected by Bell's palsy, rendering it one of the more common referrals for neurologists [<a href="#rid6">6</a>].</p><p>Bell's palsy is the appellation commonly used to describe an acute peripheral facial palsy of unknown cause. However, the terms "Bell's palsy" and "idiopathic facial paralysis" may no longer be considered synonymous [<a href="#rid6">6,7</a>]. A peripheral facial palsy is a clinical syndrome of many causes, including herpes simplex virus activation; axonal spread and multiplication of a reactivated neurotropic virus leading to inflammation, demyelination, and dysfunction is the likely cause of Bell's palsy in many adult and some pediatric cases (see <a class="local">'Herpes simplex virus'</a> below). Nevertheless, most patients with peripheral facial palsy are labelled as having Bell's palsy because there is no established or widely available method of confirming herpes simplex virus as the mechanism in clinical practice [<a href="#rid8">8</a>].</p><p>No racial, geographic, or sex-based predilection exists for Bell's palsy, but there is a threefold greater risk during pregnancy (especially in the third trimester or in the first postpartum week) [<a href="#rid9">9</a>] and a fourfold greater incidence in diabetics [<a href="#rid6">6</a>]. The risk of Bell’s palsy may also be elevated in children with an elevated body mass index (&gt;90<sup>th</sup> percentile) [<a href="#rid10">10</a>].</p><p>The most common cause of acute-onset facial nerve palsy in children has in the past been acute otitis media. However, Lyme disease may be a more common cause in endemic areas than otitis media, as illustrated by a study of 50 children with facial nerve palsy in Delaware [<a href="#rid11">11</a>]. The most common etiology was Lyme disease (50 percent), followed by acute otitis media (12 percent), varicella (6 percent), herpes zoster (4 percent), and coxsackievirus (2 percent). Idiopathic disease (Bell's palsy) was the diagnosis in 26 percent. At least one European study also found Lyme disease to be the most frequently identified cause of acute facial palsy in children, accounting for 16 of 27 cases [<a href="#rid12">12</a>]. Bilateral facial palsy occurred only in children with Lyme disease in this study. However, mumps may be a frequent infectious cause in countries where it is endemic, as parotiditis produces a localized distal compressive neuropathy [<a href="#rid13">13</a>].</p><p class="headingAnchor" id="H4"><span class="h2">Congenital facial nerve palsy</span><span class="headingEndMark"> — </span>Congenital facial nerve palsy may be the result of developmental defects or of traumatic etiology  (<a class="graphic graphic_table graphicRef76593" href="/d/graphic/76593.html" rel="external">table 1</a>). Birth weight greater than 3500 grams, forceps-assisted delivery, and prematurity are all risk factors associated with traumatic facial palsy.</p><p>Developmental defects such as congenital dysinnervation syndromes are rare causes of congenital facial palsy. The presence of multisystem dysmorphia and multiple cranial nerve abnormalities tend to favor developmental abnormalities. One well-recognized syndromic form of congenital facial palsy is Moebius syndrome, which is typically accompanied by impairment of ocular abduction and often clubfoot. Hereditary congenital facial paresis 1 and 2 are rare syndromes of isolated facial nerve dysfunction associated with genetic variants on chromosomes 3q21-22 and 10q21.3-22.1, respectively [<a href="#rid14">14-16</a>]. Other syndromes are also associated with facial palsies  (<a class="graphic graphic_table graphicRef76593" href="/d/graphic/76593.html" rel="external">table 1</a>), including branchial arch malformation sequence disorders such as Goldenhar syndrome [<a href="#rid17">17,18</a>]. (See  <a class="medical medical_review" href="/d/html/2926.html" rel="external">"Syndromes with craniofacial abnormalities", section on 'Craniofacial microsomia'</a>.)</p><p>In distinguishing developmental from traumatic facial palsies in the perinatal period, some or complete recovery of function favors traumatic lesions. Early motor nerve conduction study can help distinguish an acute from chronic facial palsy and can assist in differentiating these etiologies. (See <a class="local">'Electrodiagnostic studies'</a> below.)</p><p class="headingAnchor" id="H24001440"><span class="h3">Moebius syndrome</span><span class="headingEndMark"> — </span>Moebius (Mobius) syndrome, sometimes called Moebius sequence, is a congenital facial palsy (unilateral or bilateral) with abnormalities of abducens (cranial nerve VI) function, though other cranial nerves (III, IV, V, VIII) may be involved [<a href="#rid19">19,20</a>]. Other orthopedic malformations, including clubfoot, are also common [<a href="#rid21">21</a>]. Postmortem analysis has shown hypoplasia of the motor nucleus of the facial nerve with small or absent facial nerve rootlets exiting the brainstem [<a href="#rid22">22</a>]. A genetic cause has not yet been identified [<a href="#rid23">23</a>], but linkage points to a distinct locus at 13q12.2-13 [<a href="#rid24">24</a>]. There is some overlap with the hereditary congenital facial paresis syndromes.</p><p class="headingAnchor" id="H5"><span class="h2">Otitis media</span><span class="headingEndMark"> — </span>As mentioned above, otitis media is a relatively common cause of acute facial nerve palsy. One group found that the incidence of facial nerve palsy was 0.16 percent, which was decreased from about 2 percent in the pre-antibiotic era [<a href="#rid25">25</a>]. (See  <a class="medical medical_review" href="/d/html/6021.html" rel="external">"Acute otitis media in children: Epidemiology, microbiology, and complications", section on 'Other intratemporal complications'</a>.)</p><p>Bacterial infection of the middle ear usually is easily diagnosed by simple inspection of the external meatus and tympanic membrane. Computed tomography (CT) scan may allow for better visualization of the course of the facial nerve through the petrous portion of the temporal bone. (See  <a class="medical medical_review" href="/d/html/6009.html" rel="external">"Acute otitis media in children: Clinical manifestations and diagnosis", section on 'Diagnosis'</a>.)</p><p>The management of acute otitis media is discussed separately. (See  <a class="medical medical_review" href="/d/html/5959.html" rel="external">"Acute otitis media in children: Treatment"</a>.)</p><p class="headingAnchor" id="H6"><span class="h2">Herpes simplex virus</span><span class="headingEndMark"> — </span>Herpes simplex virus (HSV) activation is accepted as the likely cause of Bell's palsy in some pediatric cases [<a href="#rid8">8,26</a>] and most adult cases [<a href="#rid27">27,28</a>]. In one study, for example, HSV-1 genomes were identified in facial nerve endoneurial fluid and auricular muscle in 11 of 14 patients undergoing decompression surgery for Bell's palsy; the HSV-1 genomes were not found in controls [<a href="#rid29">29</a>]. In a prospective case-control study of children presenting with acute unilateral facial nerve palsy, a positive polymerase chain reaction (PCR) for HSV-1 was significantly more common in affected children (10 of 47 [21 percent]) compared with controls (4 of 45 [9 percent]) [<a href="#rid8">8</a>]. Similarly, a positive enzyme-linked immunosorbent assay (ELISA) for HSV-1 was significantly more frequent in affected children (33 of 42 [79 percent]) compared with controls (16 of 41 [39 percent]).</p><p class="headingAnchor" id="H539868757"><span class="h2">Varicella-zoster virus</span><span class="headingEndMark"> — </span>In societies where primary herpes zoster regularly occurs due to low immunization rates, varicella-zoster virus reactivation has been identified by PCR or serology in pediatric acute facial paralysis in up to 37 percent of cases [<a href="#rid30">30</a>]. Most such cases are characterized by acute peripheral facial nerve palsy in the absence of rash (ie, zoster sine herpete), while a few are notable for the presence of typical zoster lesions in the auditory canal and auricle, termed the Ramsay Hunt syndrome as discussed in the next section.</p><p class="headingAnchor" id="H3667112306"><span class="h3">Ramsay Hunt syndrome</span><span class="headingEndMark"> — </span>The Ramsay Hunt syndrome is caused by reactivation of varicella-zoster virus (herpes zoster oticus); the virus lies dormant in the sensory ganglion after primary infection. Ramsay Hunt is characterized by facial paralysis associated with a painful vesicular eruption within the external auditory canal and vestibulocochlear dysfunction. (See  <a class="medical medical_review" href="/d/html/8327.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of herpes zoster", section on 'Ramsay Hunt syndrome (herpes zoster oticus)'</a>.)</p><p class="headingAnchor" id="H7"><span class="h2">Lyme disease</span><span class="headingEndMark"> — </span>As mentioned above, Lyme disease has become the most common cause of acute facial nerve palsy among children in areas endemic for this infection [<a href="#rid11">11,12</a>]. Facial nerve palsy is the most common cranial neuropathy associated with Lyme meningitis [<a href="#rid31">31,32</a>]. Involvement of the facial nerve can be unilateral or bilateral and usually lasts less than two months [<a href="#rid33">33</a>]. (See  <a class="medical medical_review" href="/d/html/6038.html" rel="external">"Lyme disease: Clinical manifestations in children", section on 'Cranial nerve palsy'</a>.)</p><p>The mechanism by which Lyme disease causes facial nerve palsy may be related to direct invasion of the nerve by <em>Borrelia burgdorferi</em>. This possibility is suggested by retrospective studies showing that nearly all children who presented with neuroborreliosis, facial palsy, and a tick bite or erythema migrans in the head and neck region developed ipsilateral facial nerve palsy [<a href="#rid12">12,34</a>].</p><p>Patients with Lyme disease and facial nerve palsy may have other clinical features of Lyme disease, but many have no other symptoms nor a history of tick bite or erythema migrans [<a href="#rid35">35</a>]. Painless, nontender swelling and erythema of the face preceding the facial palsy are distinctive features that may be present and help confirm the clinical diagnosis [<a href="#rid36">36</a>]. The likelihood that Lyme disease is the cause of a seventh nerve palsy diminishes in either nonendemic areas or at a time of year when Lyme disease is not prevalent.</p><p>In contrast with adults, most children with isolated Lyme disease facial palsy have abnormal cerebrospinal fluid findings, including an elevated white blood cell count, protein, or both [<a href="#rid12">12,37</a>]. However, the clinical significance of these abnormalities is not clear [<a href="#rid38">38</a>]. (See <a class="local">'Lumbar puncture'</a> below.)</p><p>The evaluation of suspected Lyme-induced facial palsy is discussed separately. (See  <a class="medical medical_review" href="/d/html/6038.html" rel="external">"Lyme disease: Clinical manifestations in children", section on 'Cranial nerve palsy'</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">HIV infection</span><span class="headingEndMark"> — </span>HIV infection rarely causes facial palsy. If it does, onset is at the time of seroconversion, when a CSF lymphocytosis usually is present [<a href="#rid39">39</a>]. In the later stages when cellular immunity wanes, the facial palsy is typically caused by another infection such as zoster, chronic demyelinating polyradiculopathy, or meningeal lymphomatosis [<a href="#rid40">40</a>].</p><p class="headingAnchor" id="H10"><span class="h2">Other infections</span><span class="headingEndMark"> — </span>Other probable infectious causes of Bell's palsy include cytomegalovirus, Epstein-Barr virus, adenovirus, rubella virus, mumps, influenza B, echovirus, and coxsackievirus [<a href="#rid1">1,40,41</a>], although they have been implicated less conclusively. In addition, there are case reports of children with facial nerve palsy and serologic evidence of <em>Rickettsia conorii</em> infection (Mediterranean spotted fever) [<a href="#rid42">42</a>] and severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) [<a href="#rid43">43</a>].</p><p class="headingAnchor" id="H11"><span class="h2">Other conditions</span><span class="headingEndMark"> — </span>Several other disorders should be considered in the differential diagnosis of facial nerve palsy.</p><p class="bulletIndent1"><span class="glyph">●</span>Cholesteatoma should be suspected if the onset of facial palsy is gradual [<a href="#rid6">6</a>]. (See  <a class="medical medical_review" href="/d/html/6306.html" rel="external">"Cholesteatoma in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The Melkersson-Rosenthal syndrome is characterized by facial paralysis, episodic facial swelling, and a fissured tongue, typically beginning in adolescence but with recurrent episodes of facial palsy [<a href="#rid44">44</a>]. Abortive forms outnumber the classic triad. Perivascular tuberculoid granulomas are seen in the edematous tissue [<a href="#rid45">45</a>], but the cause is unknown and treatment is unproven.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sarcoidosis should be considered, especially in patients with bilateral facial palsy. Acute or subacute onset of bilateral facial nerve palsy may be caused by numerous other disorders, including neuroborreliosis (see <a class="local">'Lyme disease'</a> above), mumps, and Guillain-Barré syndrome [<a href="#rid46">46</a>]. (See  <a class="medical medical_review" href="/d/html/4834.html" rel="external">"Neurologic sarcoidosis"</a> and  <a class="medical medical_review" href="/d/html/6038.html" rel="external">"Lyme disease: Clinical manifestations in children", section on 'Cranial nerve palsy'</a> and  <a class="medical medical_review" href="/d/html/8310.html" rel="external">"Mumps", section on 'Neurologic complications'</a> and  <a class="medical medical_review" href="/d/html/6235.html" rel="external">"Guillain-Barré syndrome in children: Epidemiology, clinical features, and diagnosis", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe systemic hypertension has been linked to unilateral primary facial nerve palsy in children and adolescents and rarely in adults [<a href="#rid47">47</a>]. Hypertension should be suspected in a pediatric patient if facial palsy is associated with headache, altered level of consciousness, vomiting, convulsions, or focal central nervous system deficit.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute leukemia and primary brain tumors have been diagnosed infrequently mostly in younger children with acute peripheral facial palsy [<a href="#rid48">48-50</a>]. Fever and otitis media accompanied facial nerve symptoms in some but not all cases. (See  <a class="medical medical_review" href="/d/html/6244.html" rel="external">"Overview of the clinical presentation and diagnosis of acute lymphoblastic leukemia/lymphoma in children"</a> and  <a class="medical medical_review" href="/d/html/4521.html" rel="external">"Involvement of the central nervous system (CNS) with acute myeloid leukemia (AML)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Congenital myopathies, congenital myotonic dystrophy, congenital myasthenic syndromes, Guillain-Barré syndrome, and infantile botulism can also have profound facial weakness but often are accompanied by other features including ophthalmoplegia, respiratory insufficiency, or generalized weakness. (See  <a class="medical medical_review" href="/d/html/6150.html" rel="external">"Congenital myopathies"</a> and  <a class="medical medical_review" href="/d/html/5147.html" rel="external">"Myotonic dystrophy: Etiology, clinical features, and diagnosis", section on 'Congenital DM1'</a> and  <a class="medical medical_review" href="/d/html/6153.html" rel="external">"Neuromuscular junction disorders in newborns and infants", section on 'Congenital myasthenic syndromes'</a> and  <a class="medical medical_review" href="/d/html/6235.html" rel="external">"Guillain-Barré syndrome in children: Epidemiology, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6153.html" rel="external">"Neuromuscular junction disorders in newborns and infants", section on 'Infant botulism'</a>.)</p><p></p><p>Congenital unilateral lower lip palsy, also referred to as asymmetric crying facies or congenital hypoplasia of the depressor angularis oris muscle, is a typically benign cosmetic deformity that can mimic congenital facial nerve palsy [<a href="#rid51">51</a>]. It is best identified on examination of the crying infant. The affected angle of the lower lip will fail to depress, resulting in marked asymmetry compared with the normal depression of the opposite angle of the lower lip. It is distinguished from facial nerve palsy and stroke by preservation of other functions of the facial nerves, such as pursing the lips, eye closure, and nasolabial fold depth. Although typically a benign condition, it can occur with congenital heart disease in Cayler syndrome or may be associated with renal developmental abnormalities [<a href="#rid52">52,53</a>].</p><p class="headingAnchor" id="H12"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>Patients with idiopathic facial nerve palsy (Bell's palsy) typically present with the sudden onset (usually over hours) of unilateral facial paralysis. Common findings include decreased forehead movement, sagging of the eyebrow, inability to close the eye, disappearance of the nasolabial fold, and drawing of the mouth to the unaffected side [<a href="#rid4">4</a>]. Decreased tearing, hyperacusis, and/or loss of taste sensation on the anterior two-thirds of the tongue may help to site the lesion in the facial canal but are more useful as an indicator of severity than of anatomic diagnosis. The presence of an ipsilateral abducens (ie, cranial nerve VI) palsy suggests the possibility of a brainstem lesion as the cause of the facial palsy, since the abducens nucleus is in close proximity to the fibers in the brainstem that exit as the facial nerve.</p><p>Facial movement is assessed by observing the response to commands for closing the eyes, elevating the brow, frowning, showing the teeth, puckering the lips, and tensing the soft tissues of the neck. For children unable to cooperate with examination instructions, facial movement may be assessed by observing the facial appearance during laughing or crying. The examination also includes a general physical examination and neurologic examination; particular attention should be directed at the other cranial nerve functions, external ear for vesicles or scabbing (which indicates zoster), and for mass lesions within the parotid gland. Testing of taste is also helpful in localizing lesions of the facial nerve.</p><p class="headingAnchor" id="H13"><span class="h2">Peripheral versus central lesions</span><span class="headingEndMark"> — </span>Sparing of the forehead muscles is suggestive of a central (upper motor neuron) lesion because of bilateral innervation to this area. However, this finding does not exclude a peripheral site of pathology in all cases.</p><p>Central activation of the facial nerve is both volitional and automatic or emotional in origin, and the facial nerve is the final common pathway. Thus, dissociation of movement of the face to command from spontaneous movement, as in smiling, indicates an upper motor neuron lesion. Lack of dissociation indicates a lower motor neuron (peripheral) lesion.</p><p class="headingAnchor" id="H14"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of Bell's palsy is based upon the following criteria:</p><p class="bulletIndent1"><span class="glyph">●</span>A diffuse involvement of all of the distal branches of the facial nerve is present.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Onset is acute, over a day or two; the course is progressive, reaching maximal clinical weakness/paralysis within three weeks or less from the first day of visible weakness; recovery of some degree of function usually occurs within six months.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Associated prodrome, such as ear pain or hearing impairment, may be reported.</p><p></p><p>Accurate diagnosis begins with a thorough history and physical examination. The history should address the time of onset, rapidity of progression, associated symptoms (eg, hyperacusis, lack of taste), and any systemic diseases such as diabetes mellitus or chronic otitis media. A careful history should also include exposure to tick bites, history of rash, and HIV risk factors.</p><p>As mentioned, the primary etiologies of congenital facial nerve palsy include trauma and developmental abnormalities. In traumatic cases, a history of prolonged labor, forceps delivery, periauricular ecchymoses, or hemotympanum may help with diagnosis, but it is not diagnostic. It is important to look for associated dysmorphic features or multisystemic syndromal pathology. As an example, Goldenhar syndrome (craniofacial microsomia) has associated malar and maxillary hypoplasia and hemifacial microsomia, in addition to congenital facial paralysis [<a href="#rid54">54</a>].</p><p>The physical examination should include a careful assessment of facial musculature paralysis as well as careful examination of the ear, mastoid region, parotid gland, and neck. Examination of other cranial nerves, hearing, taste, salivation, and lacrimation may help localize the lesion.</p><p class="headingAnchor" id="H15"><span class="h2">Diagnostic tests</span><span class="headingEndMark"> — </span>Serologic testing for Lyme disease is recommended for all children with acute-onset facial palsy when there is the possibility of exposure. Patients who have a typical incomplete facial palsy and who recover do not need further study.</p><p>Other adjunctive investigations, such as electrodiagnostic studies, neuroimaging, or lumbar puncture, are reserved for patients with atypical clinical features to help identify an underlying etiology for facial nerve dysfunction. Atypical features include the presence of any of the following [<a href="#rid4">4</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Additional cranial neuropathies or neurologic signs</p><p class="bulletIndent1"><span class="glyph">●</span>Systemic signs (eg, otitis media, acute mastoiditis, rash, trauma)</p><p class="bulletIndent1"><span class="glyph">●</span>Sudden onset of symptoms (without progression)</p><p class="bulletIndent1"><span class="glyph">●</span>Insidious progression of symptoms beyond three weeks</p><p class="bulletIndent1"><span class="glyph">●</span>No improvement within four months</p><p></p><p>Diagnostic tests may also be used to help determine prognosis for patients with severe clinical features.</p><p class="headingAnchor" id="H192230175"><span class="h3">Lyme serologies</span><span class="headingEndMark"> — </span>Serologic testing for Lyme disease is recommended for all children with acute-onset facial palsy when there is the possibility of exposure in Lyme-endemic areas during the spring through autumn seasons. With the exception of the first four to six weeks of infection, serologic testing is highly sensitive and specific for the diagnosis of Lyme disease. Occasionally the cranial neuropathy occurs before the patient has become seropositive; in such patients, follow-up serologic testing in several weeks is typically diagnostic.</p><p>When serologic testing for Lyme disease is indicated, two-tier testing is recommended, using an enzyme-linked immunosorbent assay (ELISA) followed by a Western blot as the tests of choice (See  <a class="medical medical_review" href="/d/html/15247.html" rel="external">"Nervous system Lyme disease", section on 'Facial nerve palsy'</a> and  <a class="medical medical_review" href="/d/html/7914.html" rel="external">"Diagnosis of Lyme disease"</a>.)</p><p class="headingAnchor" id="H16"><span class="h3">Electrodiagnostic studies</span><span class="headingEndMark"> — </span>In the first days after symptoms onset, the blink reflex (stimulation of the supraorbital nerve) can confirm the peripheral origin of weakness and assess the degree of axonal conduction block [<a href="#rid55">55</a>].</p><p>The simplest electrodiagnostic test is electromyography (EMG). Even in patients who have a clinically complete lesion, needle EMG may show some potentials on active volition, which allows one to conclude that at least some axons in the nerve are still in continuity with a potential for regrowth.</p><p>Motor nerve conduction study (motor NCS, also called electroneurography or evoked electromyography) is another electrodiagnostic test used for the evaluation of facial nerve palsy. It is usually obtained in patients with complete lesions for prognostic purposes. Motor NCS involves stimulating the main branch of the facial nerve near the stylomastoid foramen and recording the compound muscle action potential (CMAP) in millivolts.</p><p>CMAP amplitudes reach their minimum level between 7 and 14 days after the onset of weakness in most patients. At approximately 10 days after the onset of symptoms, the amplitude of the CMAP on the paralyzed side compared with that on the normal side yields an estimate of the degree of axonal loss [<a href="#rid55">55</a>]. The amplitude of the paralyzed side is compared with that of the normal side and is expressed as a percentage. This percentage is presumed to correspond to the number of surviving motor neurons [<a href="#rid56">56</a>]. Thus, a CMAP value of 10 percent of normal corresponds with a degeneration or loss of 90 percent of the motor axons on that side [<a href="#rid57">57</a>]. In normal individuals, a 5 to 20 percent difference between the two sides can exist [<a href="#rid58">58</a>].</p><p>At approximately 20 to 30 days after onset, needle EMG may provide confirmation of muscle denervation and the degree of axonal damage [<a href="#rid55">55</a>]. In patients with axonal loss, needle EMG at about three months after onset may be used to assess for evidence of subclinical reinnervation from the facial nerve.</p><p class="headingAnchor" id="H17"><span class="h3">Imaging studies</span><span class="headingEndMark"> — </span>Imaging is necessary if the physical signs are atypical, if chronic otitis media, acute mastoiditis, temporal bone trauma, or a neoplasm is suspected as the etiology, if progression is slow and beyond three weeks, or if no improvement has occurred at six months. The initial imaging technique of choice for facial nerve palsies is debatable.</p><p class="bulletIndent1"><span class="glyph">●</span>One group recommends high-resolution CT in the axial and coronal planes for patients with an otoscopically demonstrable mass, history of chronic otitis media, or previous mastoid surgery [<a href="#rid2">2</a>]. Fractures of the temporal bone also are best viewed with CT scanning.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients should otherwise undergo pre- and post-contrast enhanced magnetic resonance imaging (MRI) including the brainstem, temporal bone, and parotid gland. MRI is the best study to evaluate the intraparotid facial nerve for inflammation, edema, or neoplasm. Contrast enhancement of the geniculate ganglion within the labyrinthine segment of the facial nerve is common in Bell's palsy [<a href="#rid6">6</a>]. However, contrast enhancement of the first genu and proximal tympanic segment is typically normal [<a href="#rid2">2</a>]. Enhancement of the inner ear structures occurs only in herpes zoster facial palsy and can be taken to suggest this diagnosis even without a vesicular eruption [<a href="#rid59">59</a>].</p><p></p><p class="headingAnchor" id="H18"><span class="h3">Lumbar puncture</span><span class="headingEndMark"> — </span>Lumbar puncture is recommended for children with cranial nerve palsy when there is clinical suspicion of meningitis (eg, severe or prolonged headache, fever, papilledema, or nuchal rigidity); cerebrospinal fluid analysis may reveal an increased white blood cell count or protein in cases of facial palsy associated with central nervous system infection [<a href="#rid60">60</a>]. A slight increase in monocytes and lymphocytes is compatible with Bell's palsy but does not definitively diagnose the condition nor exclude an inflammatory process. The cerebrospinal fluid concentration of antibody to <em>B. burgdorferi</em> is highly specific for the diagnosis of central nervous system Lyme disease. (See  <a class="medical medical_review" href="/d/html/6325.html" rel="external">"Lumbar puncture in children"</a> and  <a class="medical medical_review" href="/d/html/6038.html" rel="external">"Lyme disease: Clinical manifestations in children", section on 'Cranial nerve palsy'</a>.)</p><p>Cerebrospinal fluid analysis is of limited utility for the diagnosis of Lyme disease when involvement is restricted to the peripheral nervous system, (eg, isolated facial nerve palsy and no signs of meningitis). Therefore, we suggest that children who have facial nerve palsy and Lyme disease undergo lumbar puncture only if they have clinical evidence of central nervous system infection. This suggestion is in agreement with the recommendations of the Infectious Diseases Society of America and the American Academy of Neurology [<a href="#rid61">61,62</a>]. (See  <a class="medical medical_review" href="/d/html/15247.html" rel="external">"Nervous system Lyme disease", section on 'Facial nerve palsy'</a> and  <a class="medical medical_review" href="/d/html/6038.html" rel="external">"Lyme disease: Clinical manifestations in children", section on 'Cranial nerve palsy'</a>.)</p><p class="headingAnchor" id="H20"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>The treatment of facial nerve palsy in children is guided by the etiology and the severity of the condition [<a href="#rid4">4</a>].</p><p>The treatment of facial nerve palsy due to a specific cause (eg, Lyme disease or acute otitis media) involves treatment of the underlying disorder. (See  <a class="medical medical_review" href="/d/html/7896.html" rel="external">"Treatment of Lyme disease"</a> and  <a class="medical medical_review" href="/d/html/5959.html" rel="external">"Acute otitis media in children: Treatment"</a>.)</p><p>Treatment options for congenital or permanently acquired lesions include muscle transfers and nerve grafts. In both acquired and congenital facial palsies, care must be taken to protect the cornea of the affected side. Congenital unilateral lower lip palsy can be treated with botulinum injections to the unaffected side.</p><p class="headingAnchor" id="H21"><span class="h2">Eye care</span><span class="headingEndMark"> — </span>Appropriate eye care is required to help avoid corneal abrasions if the patient with facial palsy is unable to close the eye. This care generally entails administration of <a class="drug drug_pediatric" data-topicid="17056" href="/d/drug information/17056.html" rel="external">artificial tears</a> during the day with ophthalmic ointment and patching at night; tape should not be placed directly on the eyelid because the patch could slip and abrade the cornea. Rarely, tarsorrhaphy or temporary implantation of a gold weight into the upper lid is required.</p><p class="headingAnchor" id="H22"><span class="h2">Drug therapy for Bell's palsy</span><span class="headingEndMark"> — </span>Given the established benefit of glucocorticoid treatment for adults with Bell's palsy, we recommend early treatment with oral glucocorticoids for all children with Bell's palsy. This recommendation is consistent with guidelines from the American Academy of Neurology [<a href="#rid63">63</a>]. Treatment should preferably begin within three days of symptom onset. Our suggested regimen is <a class="drug drug_pediatric" data-topicid="12725" href="/d/drug information/12725.html" rel="external">prednisone</a> 2 mg/kg daily (up to 60 to 80 mg) for five days, followed by a five-day taper. At least two studies have found that doses of 1 mg/kg may be similarly effective [<a href="#rid64">64,65</a>].</p><p>Early combined therapy with oral glucocorticoids plus <a class="drug drug_pediatric" data-topicid="13001" href="/d/drug information/13001.html" rel="external">valacyclovir</a> (20 mg/kg per dose three times daily, maximum 1000 mg per dose) for one week for children with severe Bell's palsy (ie, a House-Brackman  (<a class="graphic graphic_table graphicRef70562" href="/d/graphic/70562.html" rel="external">table 2</a>) grade IV or higher) may marginally reduce risk of long-term sequelae, as discussed below. However, there is no consensus among experts regarding the use of antivirals combined with glucocorticoids to treat Bell's palsy in children.</p><p>Patients with Ramsay Hunt syndrome should be treated with <a class="drug drug_pediatric" data-topicid="12725" href="/d/drug information/12725.html" rel="external">prednisone</a> plus <a class="drug drug_pediatric" data-topicid="13247" href="/d/drug information/13247.html" rel="external">acyclovir</a> or <a class="drug drug_pediatric" data-topicid="13001" href="/d/drug information/13001.html" rel="external">valacyclovir</a>. (See  <a class="medical medical_review" href="/d/html/8293.html" rel="external">"Treatment of herpes zoster", section on 'Ramsay Hunt syndrome'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Efficacy of glucocorticoids</strong> – The mainstay of pharmacologic therapy for Bell's palsy in adults is early short-term oral glucocorticoid treatment, which is established as effective by systematic reviews and meta-analyses [<a href="#rid66">66-70</a>] of randomized controlled trials [<a href="#rid71">71-77</a>]. (See  <a class="medical medical_review" href="/d/html/5286.html" rel="external">"Bell's palsy: Treatment and prognosis in adults", section on 'Glucocorticoids for all patients'</a>.)</p><p></p><p class="bulletIndent1">The benefit of glucocorticoids in children with Bell's palsy is less well-established, likely partially due to studies including children with mild symptoms as well as the high rates of spontaneous recovery over the long-term in these patients [<a href="#rid78">78</a>]. One placebo-controlled trial of 42 children with severe facial palsy found that the rate of normal nerve function was slightly higher in patients assigned to glucocorticoid at four and six months of follow-up (86 and 100 percent in treated versus 72 and 86 percent untreated controls), but all patients improved by 12 months [<a href="#rid79">79</a>]. However, in another trial of 187 children with symptoms &lt;72 hour duration, recovery of facial function was similar for those assigned either to <a class="drug drug_pediatric" data-topicid="12723" href="/d/drug information/12723.html" rel="external">prednisolone</a> or placebo both at one-month (49 versus 57 percent; adjusted odds ratio [aOR] 0.7, 95% CI 0.4-1.3) and up to final follow-up at six months (99 versus 93 percent; aOR 3.0, 95% CI 0.5-17.7) [<a href="#rid80">80</a>]. Other lower-quality studies have not shown specific long-term benefit of glucocorticoid therapy versus conservative management [<a href="#rid81">81</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Efficacy of antiviral therapy with or without glucocorticoids</strong> – The suspicion that Bell's palsy is frequently caused by herpes simplex virus (see <a class="local">'Herpes simplex virus'</a> above) led to adult trials of antiviral therapy with or without glucocorticoids [<a href="#rid71">71-77</a>]. These trials found no benefit for antiviral therapy alone compared with placebo and conflicting evidence of additional benefit for antiviral agents when combined with glucocorticoids.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a 2009 meta-analysis involving 18 trials and 2786 patients, treatment with glucocorticoids alone was associated with a reduced risk of unfavorable recovery (relative risk [RR] 0.69, 95% CI 0.55-0.87), whereas treatment with antiviral agents alone was not (RR 1.14, 95% CI 0.80-1.62) [<a href="#rid66">66</a>]. In pooled data from eight trials, the same meta-analysis found a trend toward a reduced risk of unfavorable recovery for combined antiviral and glucocorticoid treatment compared with glucocorticoid treatment alone, but the outcome just missed statistical significance (RR 0.75, 95% CI 0.56-1.0).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a second 2009 meta-analysis of six trials and 1145 patients, there was no significant benefit of combined antiviral and glucocorticoid treatment for achieving at least partial facial muscle recovery (odds ratio 1.5, 95% CI 0.83-2.69) [<a href="#rid67">67</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A 2019 meta-analysis of three trials at low risk of bias (n = 766 participants) concluded there was little to no effect in rates of incomplete recovery with combination antiviral and glucocorticoid therapy compared with glucocorticoid therapy alone (RR 0.81, 95% CI 0.38-1.74), even for the subgroup with severe Bell's palsy (RR 0.82, 95% CI 0.57-1.17; 2 trials, n = 98) [<a href="#rid82">82</a>]. However, when all available evidence was included (13 trials, 1729 participants), the rate of incomplete recovery was lower after antiviral and glucocorticoid therapy than glucocorticoid alone (RR 0.59, 95% CI 0.47-0.70).</p><p></p><p class="headingAnchor" id="H24"><span class="h2">Surgery</span><span class="headingEndMark"> — </span>The early surgical management of facial nerve palsy in the pediatric population has not been systematically studied. One uncontrolled study evaluating middle cranial fossa decompression of the labyrinthine segment of the facial nerve demonstrated benefit for patients in whom electrodiagnostic studies show a ≥90 percent reduction of the compound muscle action potential [<a href="#rid83">83</a>]. At least two uncontrolled case series in patients with severe Bell's palsy have shown improvement following facial nerve decompression performed as late as 70 to 89 days after symptom onset [<a href="#rid84">84,85</a>]. Another study suggested that facial nerve decompression prevented further episodes of facial palsy but did not promote facial nerve recovery [<a href="#rid86">86</a>].</p><p>However, a 2001 practice parameter from the American Academy of Neurology determined that the surgical treatment of facial nerve palsy could not be recommended due to concerns about the inherent bias of these studies and the potential complication of hearing loss [<a href="#rid87">87</a>]. A 2013 guideline from the American Academy of Otolaryngology-Head and Neck Surgery Foundation made no recommendation regarding surgical decompression because the evidence consisted of low-quality, nonrandomized studies [<a href="#rid88">88</a>]. Thus, the use of early surgery for children with facial nerve palsy should be studied further before considering this as a treatment option.</p><p>Surgical reanimation techniques may be considered in children with congenital or permanently acquired facial nerve palsy [<a href="#rid89">89,90</a>]. These techniques do not completely restore normal physiologic function, although they may aid the child psychologically. Surgical procedures are divided into static procedures that provide symmetry of the mouth at rest and reanimation techniques that allow facial expression [<a href="#rid90">90-94</a>]. They may involve regional muscle transfers, nerve crossovers, cable grafts, and free muscle grafts. These procedures are advocated in early school age, when the child may have some understanding of the procedure [<a href="#rid54">54</a>].</p><p class="headingAnchor" id="H1316840435"><span class="h1">PROGNOSIS AND NATURAL HISTORY</span><span class="headingEndMark"> — </span>The prognosis of individual cases of facial paralysis can be difficult to assess and is based upon the underlying cause.</p><p class="bulletIndent1"><span class="glyph">●</span>Congenital facial palsies have a poor prognosis for recovery of function because of insufficient development of the facial nerve or canal.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Traumatic facial paralysis in the perinatal period has an excellent prognosis, with 100 percent of patients showing some degree of improvement of function on the affected side.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Most studies have focused on the prognosis of Bell's palsy and found that the majority of cases recover with minimal, if any, dysfunction [<a href="#rid64">64,95,96</a>]. The Copenhagen Facial Nerve study evaluated the natural history of 2570 cases of peripheral nerve palsy over a 25-year period, including 463 children younger than 15 years old [<a href="#rid95">95</a>]. A full recovery was achieved by 90 percent of these children. Many studies of acquired facial nerve palsy in children show excellent recovery rates of over 97 percent [<a href="#rid5">5,97,98</a>]. In one retrospective cohort of 102 children, 101 made a full recovery, with early recovery (by one month) weakly associated with lower doses of glucocorticoids, faster initiation of steroid treatment, and lesser severity of facial palsy on the 10<sup>th</sup> day [<a href="#rid64">64</a>]. Another smaller retrospective cohort of 53 children with Bell's palsy found that children under eight years of age had a higher recovery rate by one month compared with older children [<a href="#rid99">99</a>]. Nearly all the children in these retrospective studies received glucocorticoid treatment, and a minority also received antiviral therapy. In another case series of 32 episodes of Bell's palsy in 29 children, complete recovery occurred in 31 episodes and was unrelated to treatment with glucocorticoids [<a href="#rid96">96</a>].</p><p></p><p>The prognosis of nerve injury is related primarily to the type and severity of the lesion [<a href="#rid100">100</a>]. A simple rule is that clinically incomplete lesions tend to recover. For facial nerve palsy, the House-Brackmann grading system was devised both as a clinical indicator of severity as well as an objective record of progress  (<a class="graphic graphic_table graphicRef70562" href="/d/graphic/70562.html" rel="external">table 2</a>) [<a href="#rid101">101</a>]. On this scale, grades I and II have good outcomes, grades III and IV characterize moderate dysfunction, and grades V and VI portend a poor result, although studies in children show good outcomes even in those with grades IV to VI [<a href="#rid64">64,97</a>]. Limited data suggest that electrophysiologic measures of facial nerve function are more reliable than the House-Brackmann for estimating prognosis in cases with more severe facial nerve injury [<a href="#rid102">102</a>].</p><p>Motor nerve conduction studies have proved useful for determining the prognosis of idiopathic facial palsy. One study of facial motor nerve conduction study performed three to seven days after onset showed that 79 percent of those with a frontalis compound muscle action potential (CMAP) amplitude greater than 50 percent of the unaffected side had a good recovery by three months, compared with 48 percent of those with smaller CMAP amplitudes [<a href="#rid103">103</a>]. Another group noted that 84 percent of patients with CMAP amplitude responses greater than 30 percent of normal had complete recovery of facial function [<a href="#rid104">104</a>]. A CMAP response less than 10 percent suggests a poor prognosis and surgical consideration [<a href="#rid105">105</a>], although one-third of patients may have complete recovery even when CMAP amplitudes show 90 to 98 percent degeneration. In one study of patients with 90 percent reduction in CMAP who underwent middle cranial fossa decompression, 50 percent had a better final recovery than did control patients [<a href="#rid106">106</a>].</p><p>The prognosis of Bell's palsy is favorable if some recovery is seen within the first 21 days of onset [<a href="#rid107">107</a>]. A diagnosis of Bell's palsy is doubtful if some facial function, however small, has not returned within three to four months, and additional evaluation to determine the etiology is warranted [<a href="#rid108">108</a>].</p><p>In severe lesions that recover, the outgrowth of new axons from the injury site is not discretely directed but is disorganized and misdirected; on volitional activation of the facial nerve, a mass action of facial musculature or synkinesis ensues. Thus, on blinking, there is twitching of the angle of the mouth, and, on smiling, the eye may close or wink. Similarly, with misdirected autonomic fibers, a salivary stimulus may result in excess lacrimation, the syndrome of "crocodile tears." Synkinesis can be managed with a combination of botulinum toxin injections for selective chemodenervation of affected muscle groups and facial neuromuscular retraining [<a href="#rid109">109</a>].</p><p>The recurrence rate of Bell's palsy in children is less than 10 percent, similar to that in adults, and can occur months to years from the initial occurrence and on the same or contralateral side [<a href="#rid110">110</a>]. One series in children found recurrences in 11 of 182 patients (6 percent), two of which were associated with the Melkersson-Rosenthal syndrome [<a href="#rid111">111</a>]. Recurrence of facial palsy is more frequent, and prognosis is worse in patients with Melkersson-Rosenthal syndrome than in those with recurrent Bell's palsy [<a href="#rid112">112,113</a>]. Facial nerve decompression may be beneficial for recurrent facial nerve palsy associated with Melkersson-Rosenthal syndrome [<a href="#rid114">114</a>].</p><p>Recurrence of facial nerve palsy should prompt a search for associated findings that may suggest a diagnosis other than Bell's palsy. Imaging should be performed to evaluate for any structural abnormalities. In addition, the blood pressure should be evaluated, since hypertension has been linked with recurrent facial nerve palsy in children [<a href="#rid115">115</a>].</p><p class="headingAnchor" id="H2100206567"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/112593.html" rel="external">"Society guideline links: Bell's palsy"</a>.)</p><p class="headingAnchor" id="H4519763"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anatomy </strong>– The facial nerve has a complex anatomy and function that renders it susceptible to multiple neurologic disorders based upon the location of the lesion  (<a class="graphic graphic_figure graphicRef138653" href="/d/graphic/138653.html" rel="external">figure 1</a>). (See <a class="local">'Facial nerve anatomy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiologies </strong>– Approximately one-half of all cases qualify for the label "Bell's palsy," defined as an acute facial nerve palsy of unknown cause. Specific causes of facial nerve palsy include congenital, infectious, neoplastic, traumatic, and idiopathic etiologies  (<a class="graphic graphic_table graphicRef76593" href="/d/graphic/76593.html" rel="external">table 1</a>). Important infectious etiologies include otitis media, herpes simplex viral infection, Lyme disease, Ramsay Hunt syndrome, and HIV infection. (See <a class="local">'Etiology and epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features </strong>– Patients with facial nerve palsy typically present with the acute onset of unilateral facial paralysis. Common findings include sagging of the eyebrow, inability to close the eye, disappearance of the nasolabial fold, and drawing of the mouth to the unaffected side. Decreased tearing, hyperacusis, and/or loss of taste sensation on the anterior two-thirds of the tongue may also occur. (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis of idiopathic facial palsy </strong>– The diagnosis of idiopathic (Bell's) facial nerve palsy is based upon the following criteria (see <a class="local">'Diagnosis'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A diffuse involvement of all of the distal branches of the facial nerve is present.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Onset is acute, over a day or two; the course is progressive, reaching maximal clinical weakness/paralysis within three weeks or less from the first day of visible weakness; recovery of some degree of function usually occurs within six months.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic testing to evaluate for underlying causes </strong>– Serologic testing for Lyme disease is recommended for all children with acute-onset facial palsy when there is the possibility of exposure. Additional testing is warranted for patients with atypical presentations. (See <a class="local">'Diagnostic tests'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Imaging </strong>– Neuroimaging is warranted if the physical signs are atypical, if alternative diagnoses are suspected, if progression is slow and extends beyond three weeks, or if no improvement has occurred at six months. We perform either high-resolution CT in the axial and coronal planes or MRI of the brain and parotid gland with gadolinium contrast. (See <a class="local">'Imaging studies'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other studies </strong>– Adjunctive investigations such as lumbar puncture and electrodiagnostic studies are reserved for selected patients with atypical features or clinical course. (See <a class="local">'Lumbar puncture'</a> above and <a class="local">'Electrodiagnostic studies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment of idiopathic facial palsy</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Eye care </strong>– In both acquired and congenital facial palsies, care must be taken to protect the cornea of the affected side. Appropriate eye care entails administration of <a class="drug drug_pediatric" data-topicid="17056" href="/d/drug information/17056.html" rel="external">artificial tears</a> during the day with ophthalmic ointment and patching at night. (See <a class="local">'Eye care'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pharmacotherapy </strong>– For children with idiopathic acquired facial palsy (ie, Bell's palsy), we recommend early treatment with oral glucocorticoids (<a class="grade" href="https://medilib.ir/uptodate/show/grade_2" rel="external">Grade 1B</a>). Treatment should preferably begin within three days of symptom onset. Our suggested regimen is <a class="drug drug_pediatric" data-topicid="12725" href="/d/drug information/12725.html" rel="external">prednisone</a> 1 to 2 mg/kg daily (up to 60 to 80 mg) for five days, followed by a five-day taper. (See <a class="local">'Drug therapy for Bell's palsy'</a> above.)</p><p></p><p class="bulletIndent2">Combination therapy with <a class="drug drug_pediatric" data-topicid="12725" href="/d/drug information/12725.html" rel="external">prednisone</a> plus <a class="drug drug_pediatric" data-topicid="13001" href="/d/drug information/13001.html" rel="external">valacyclovir</a> 20 mg/kg per dose three times daily (maximum 1000 mg per dose) for one week may reduce the risk of long-term sequelae. However, data from adult trials suggest only marginal additional benefit of combination therapy, and high-quality data for children are lacking. (See <a class="local">'Drug therapy for Bell's palsy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of other causes </strong>– The management of facial nerve palsy due to a specific cause (eg, Lyme disease or acute otitis media) involves treatment of the underlying disorder.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prognosis </strong>– Most children with Bell's palsy recover with minimal, if any, dysfunction. The prognosis for other causes of facial paralysis varies based upon the natural history of the underlying cause. (See <a class="local">'Prognosis and natural history'</a> above.)</p><p></p><p class="headingAnchor" id="H36326959"><span class="h1">ACKNOWLEDGMENTS</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Robert P Cruse, DO and Thomas J Geller, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Roob G, Fazekas F, Hartung HP. Peripheral facial palsy: etiology, diagnosis and treatment. Eur Neurol 1999; 41:3.</a></li><li><a class="nounderline abstract_t">Swartz JD, Harnsberger HR, Mukherji SK. The temporal bone. Contemporary diagnostic dilemmas. Radiol Clin North Am 1998; 36:819.</a></li><li class="breakAll">Wilson-Pauwels L, Akesson E, Stewart P. Cranial nerves: Anatomy and clinical comments, BC Decker, Philadelphia 1988. p.81.</li><li><a class="nounderline abstract_t">Shargorodsky J, Lin HW, Gopen Q. Facial nerve palsy in the pediatric population. Clin Pediatr (Phila) 2010; 49:411.</a></li><li><a class="nounderline abstract_t">Karalok ZS, Taskin BD, Ozturk Z, et al. Childhood peripheral facial palsy. Childs Nerv Syst 2018; 34:911.</a></li><li><a class="nounderline abstract_t">Jackson CG, von Doersten PG. The facial nerve. Current trends in diagnosis, treatment, and rehabilitation. Med Clin North Am 1999; 83:179.</a></li><li><a class="nounderline abstract_t">James DG. All that palsies is not Bell's. J R Soc Med 1996; 89:184.</a></li><li><a class="nounderline abstract_t">Khine H, Mayers M, Avner JR, et al. Association between herpes simplex virus-1 infection and idiopathic unilateral facial paralysis in children and adolescents. Pediatr Infect Dis J 2008; 27:468.</a></li><li><a class="nounderline abstract_t">Hilsinger RL Jr, Adour KK, Doty HE. Idiopathic facial paralysis, pregnancy, and the menstrual cycle. Ann Otol Rhinol Laryngol 1975; 84:433.</a></li><li><a class="nounderline abstract_t">Breitling V, Leha A, Schiller S, et al. Association of Overweight and Obesity With Bell Palsy in Children. Pediatr Neurol 2023; 139:43.</a></li><li><a class="nounderline abstract_t">Cook SP, Macartney KK, Rose CD, et al. Lyme disease and seventh nerve paralysis in children. Am J Otolaryngol 1997; 18:320.</a></li><li><a class="nounderline abstract_t">Christen HJ, Bartlau N, Hanefeld F, et al. Peripheral facial palsy in childhood--Lyme borreliosis to be suspected unless proven otherwise. Acta Paediatr Scand 1990; 79:1219.</a></li><li><a class="nounderline abstract_t">Folayan MO, Arobieke RI, Eziyi E, et al. Facial nerve palsy: analysis of cases reported in children in a suburban hospital in Nigeria. Niger J Clin Pract 2014; 17:23.</a></li><li><a class="nounderline abstract_t">Kremer H, Kuyt LP, van den Helm B, et al. Localization of a gene for Möbius syndrome to chromosome 3q by linkage analysis in a Dutch family. Hum Mol Genet 1996; 5:1367.</a></li><li><a class="nounderline abstract_t">Verzijl HT, van der Zwaag B, Lammens M, et al. The neuropathology of hereditary congenital facial palsy vs Möbius syndrome. Neurology 2005; 64:649.</a></li><li><a class="nounderline abstract_t">Verzijl HT, van den Helm B, Veldman B, et al. A second gene for autosomal dominant Möbius syndrome is localized to chromosome 10q, in a Dutch family. Am J Hum Genet 1999; 65:752.</a></li><li><a class="nounderline abstract_t">Jankauskienė A, Azukaitis K. Congenital unilateral facial nerve palsy as an unusual presentation of BOR syndrome. Eur J Pediatr 2013; 172:273.</a></li><li><a class="nounderline abstract_t">Traboulsi EI. Congenital cranial dysinnervation disorders and more. J AAPOS 2007; 11:215.</a></li><li><a class="nounderline abstract_t">Verzijl HT, van der Zwaag B, Cruysberg JR, Padberg GW. Möbius syndrome redefined: a syndrome of rhombencephalic maldevelopment. Neurology 2003; 61:327.</a></li><li><a class="nounderline abstract_t">Cattaneo L, Chierici E, Bianchi B, et al. The localization of facial motor impairment in sporadic Möbius syndrome. Neurology 2006; 66:1907.</a></li><li><a class="nounderline abstract_t">K McClure P, Kilinc E, Oishi S, et al. Mobius Syndrome: A 35-Year Single Institution Experience. J Pediatr Orthop 2017; 37:e446.</a></li><li><a class="nounderline abstract_t">Hanissian AS, Fuste F, Hayes WT, Duncan JM. Möbius syndrome in twins. Am J Dis Child 1970; 120:472.</a></li><li><a class="nounderline abstract_t">MacKinnon S, Oystreck DT, Andrews C, et al. Diagnostic distinctions and genetic analysis of patients diagnosed with moebius syndrome. Ophthalmology 2014; 121:1461.</a></li><li><a class="nounderline abstract_t">Slee JJ, Smart RD, Viljoen DL. Deletion of chromosome 13 in Moebius syndrome. J Med Genet 1991; 28:413.</a></li><li class="breakAll">Pollack R, Brown L. Facial paralysis in otitis media. In: Disorders of the facial nerve: Anatomy, diagnosis, and management, Graham M, House W (Eds), Raven Press, 1982. p.221.</li><li><a class="nounderline abstract_t">Kanerva M, Nissinen J, Moilanen K, et al. Microbiologic findings in acute facial palsy in children. Otol Neurotol 2013; 34:e82.</a></li><li><a class="nounderline abstract_t">Baringer JR. Herpes simplex virus and Bell palsy. Ann Intern Med 1996; 124:63.</a></li><li><a class="nounderline abstract_t">Schirm J, Mulkens PS. Bell's palsy and herpes simplex virus. APMIS 1997; 105:815.</a></li><li><a class="nounderline abstract_t">Murakami S, Mizobuchi M, Nakashiro Y, et al. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 1996; 124:27.</a></li><li><a class="nounderline abstract_t">Furuta Y, Ohtani F, Aizawa H, et al. Varicella-zoster virus reactivation is an important cause of acute peripheral facial paralysis in children. Pediatr Infect Dis J 2005; 24:97.</a></li><li><a class="nounderline abstract_t">Ackermann R, Hörstrup P, Schmidt R. Tick-borne meningopolyneuritis (Garin-Bujadoux, Bannwarth). Yale J Biol Med 1984; 57:485.</a></li><li><a class="nounderline abstract_t">Pachner AR, Steere AC. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology 1985; 35:47.</a></li><li><a class="nounderline abstract_t">Clark JR, Carlson RD, Sasaki CT, et al. Facial paralysis in Lyme disease. Laryngoscope 1985; 95:1341.</a></li><li><a class="nounderline abstract_t">Christen HJ. Lyme neuroborreliosis in children. Ann Med 1996; 28:235.</a></li><li><a class="nounderline abstract_t">Smouha EE, Coyle PK, Shukri S. Facial nerve palsy in Lyme disease: evaluation of clinical diagnostic criteria. Am J Otol 1997; 18:257.</a></li><li><a class="nounderline abstract_t">Markby DP. Lyme disease facial palsy: differentiation from Bell's palsy. BMJ 1989; 299:605.</a></li><li><a class="nounderline abstract_t">Belman AL, Reynolds L, Preston T, et al. Cerebrospinal fluid findings in children with Lyme disease-associated facial nerve palsy. Arch Pediatr Adolesc Med 1997; 151:1224.</a></li><li><a class="nounderline abstract_t">Shapiro ED, Gerber MA. Lyme disease and facial nerve palsy. Arch Pediatr Adolesc Med 1997; 151:1183.</a></li><li><a class="nounderline abstract_t">Murr AH, Benecke JE Jr. Association of facial paralysis with HIV positivity. Am J Otol 1991; 12:450.</a></li><li><a class="nounderline abstract_t">Morgan M, Nathwani D. Facial palsy and infection: the unfolding story. Clin Infect Dis 1992; 14:263.</a></li><li><a class="nounderline abstract_t">Papan C, Keeren K, Schroten H, Tenenbaum T. Peripheral Facial Nerve Palsy in Children With Enterovirus Infection. Pediatr Infect Dis J 2020; 39:e326.</a></li><li><a class="nounderline abstract_t">Bitsori M, Galanakis E, Papadakis CE, Sbyrakis S. Facial nerve palsy associated with Rickettsia conorii infection. Arch Dis Child 2001; 85:54.</a></li><li><a class="nounderline abstract_t">Zain S, Petropoulou K, Mirchia K, et al. COVID-19 as a rare cause of facial nerve neuritis in a pediatric patient. Radiol Case Rep 2021; 16:1400.</a></li><li><a class="nounderline abstract_t">Levenson MJ, Ingerman M, Grimes C, Anand KV. Melkersson-Rosenthal syndrome. Arch Otolaryngol 1984; 110:540.</a></li><li><a class="nounderline abstract_t">Hornstein OP, Stosiek N, Schönberger A, Meisel-Stosiek M. [Classification and scope of clinical variations of Melkersson-Rosenthal syndrome]. Z Hautkr 1987; 62:1453.</a></li><li><a class="nounderline abstract_t">Teller DC, Murphy TP. Bilateral facial paralysis: a case presentation and literature review. J Otolaryngol 1992; 21:44.</a></li><li><a class="nounderline abstract_t">Jörg R, Milani GP, Simonetti GD, et al. Peripheral facial nerve palsy in severe systemic hypertension: a systematic review. Am J Hypertens 2013; 26:351.</a></li><li><a class="nounderline abstract_t">Babl FE, Kochar A, Osborn M, et al. Risk of Leukemia in Children With Peripheral Facial Palsy. Ann Emerg Med 2021; 77:174.</a></li><li><a class="nounderline abstract_t">Krishnamurthy S, Weinstock AL, Smith SH, Duffner PK. Facial palsy, an unusual presenting feature of childhood leukemia. Pediatr Neurol 2002; 27:68.</a></li><li><a class="nounderline abstract_t">Walsh PS, Gray JM, Ramgopal S, Lipshaw MJ. Risk of malignancy following emergency department Bell's palsy diagnosis in children. Am J Emerg Med 2022; 53:63.</a></li><li><a class="nounderline abstract_t">Kobayashi T. Congenital unilateral lower lip palsy. Acta Otolaryngol 1979; 88:303.</a></li><li><a class="nounderline abstract_t">Caksen H, Odabaş D, Tuncer O, et al. A review of 35 cases of asymmetric crying facies. Genet Couns 2004; 15:159.</a></li><li><a class="nounderline abstract_t">Pasick C, McDonald-McGinn DM, Simbolon C, et al. Asymmetric crying facies in the 22q11.2 deletion syndrome: implications for future screening. Clin Pediatr (Phila) 2013; 52:1144.</a></li><li><a class="nounderline abstract_t">Shapiro NL, Cunningham MJ, Parikh SR, et al. Congenital unilateral facial paralysis. Pediatrics 1996; 97:261.</a></li><li><a class="nounderline abstract_t">Valls-Solé J. Electrodiagnostic studies of the facial nerve in peripheral facial palsy and hemifacial spasm. Muscle Nerve 2007; 36:14.</a></li><li><a class="nounderline abstract_t">Qiu WW, Yin SS, Stucker FJ, et al. Time course of Bell palsy. Arch Otolaryngol Head Neck Surg 1996; 122:967.</a></li><li><a class="nounderline abstract_t">Halvorson DJ, Coker NJ, Wang-Bennett LT. Histologic correlation of the degenerating facial nerve with electroneurography. Laryngoscope 1993; 103:178.</a></li><li><a class="nounderline abstract_t">Austin JR, Peskind SP, Austin SG, Rice DH. Idiopathic facial nerve paralysis: a randomized double blind controlled study of placebo versus prednisone. Laryngoscope 1993; 103:1326.</a></li><li><a class="nounderline abstract_t">Kuo MJ, Drago PC, Proops DW, Chavda SV. Early diagnosis and treatment of Ramsay Hunt syndrome: the role of magnetic resonance imaging. J Laryngol Otol 1995; 109:777.</a></li><li><a class="nounderline abstract_t">Papan C, Kremp L, Weiß C, et al. Infectious causes of peripheral facial nerve palsy in children-a retrospective cohort study with long-term follow-up. Eur J Clin Microbiol Infect Dis 2019; 38:2177.</a></li><li><a class="nounderline abstract_t">Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clin Infect Dis 2021; 72:e1.</a></li><li><a class="nounderline abstract_t">Halperin JJ, Shapiro ED, Logigian E, et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2007; 69:91.</a></li><li><a class="nounderline abstract_t">Gronseth GS, Paduga R, American Academy of Neurology. Evidence-based guideline update: steroids and antivirals for Bell palsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2012; 79:2209.</a></li><li><a class="nounderline abstract_t">Karatoprak E, Yilmaz S. Prognostic Factors Associated With Recovery in Children With Bell's Palsy. J Child Neurol 2019; 34:891.</a></li><li><a class="nounderline abstract_t">Arican P, Dundar NO, Gencpinar P, Cavusoglu D. Efficacy of Low-Dose Corticosteroid Therapy Versus High-Dose Corticosteroid Therapy in Bell's Palsy in Children. J Child Neurol 2017; 32:72.</a></li><li><a class="nounderline abstract_t">de Almeida JR, Al Khabori M, Guyatt GH, et al. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA 2009; 302:985.</a></li><li><a class="nounderline abstract_t">Quant EC, Jeste SS, Muni RH, et al. The benefits of steroids versus steroids plus antivirals for treatment of Bell's palsy: a meta-analysis. BMJ 2009; 339:b3354.</a></li><li><a class="nounderline abstract_t">van der Veen EL, Rovers MM, de Ru JA, van der Heijden GJ. A small effect of adding antiviral agents in treating patients with severe Bell palsy. Otolaryngol Head Neck Surg 2012; 146:353.</a></li><li><a class="nounderline abstract_t">Salinas RA, Alvarez G, Daly F, Ferreira J. Corticosteroids for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2010; :CD001942.</a></li><li><a class="nounderline abstract_t">Turgeon RD, Wilby KJ, Ensom MH. Antiviral treatment of Bell's palsy based on baseline severity: a systematic review and meta-analysis. Am J Med 2015; 128:617.</a></li><li><a class="nounderline abstract_t">Adour KK, Ruboyianes JM, Von Doersten PG, et al. Bell's palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial. Ann Otol Rhinol Laryngol 1996; 105:371.</a></li><li><a class="nounderline abstract_t">Antunes ML, Fukuda Y, Testa JR. [Clinical treatment of Bell's palsy: comparative study among valaciclovir plus deflazacort, deflazacort and placebo]. Acta AWHO 2000; 19:68.</a></li><li><a class="nounderline abstract_t">Kawaguchi K, Inamura H, Abe Y, et al. Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy. Laryngoscope 2007; 117:147.</a></li><li><a class="nounderline abstract_t">Hato N, Yamada H, Kohno H, et al. Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol 2007; 28:408.</a></li><li><a class="nounderline abstract_t">Sullivan FM, Swan IR, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med 2007; 357:1598.</a></li><li><a class="nounderline abstract_t">Yeo SG, Lee YC, Park DC, Cha CI. Acyclovir plus steroid vs steroid alone in the treatment of Bell's palsy. Am J Otolaryngol 2008; 29:163.</a></li><li><a class="nounderline abstract_t">Engström M, Berg T, Stjernquist-Desatnik A, et al. Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol 2008; 7:993.</a></li><li><a class="nounderline abstract_t">Pitaro J, Waissbluth S, Daniel SJ. Do children with Bell's palsy benefit from steroid treatment? A systematic review. Int J Pediatr Otorhinolaryngol 2012; 76:921.</a></li><li><a class="nounderline abstract_t">Unüvar E, Oğuz F, Sidal M, Kiliç A. Corticosteroid treatment of childhood Bell's palsy. Pediatr Neurol 1999; 21:814.</a></li><li><a class="nounderline abstract_t">Babl FE, Herd D, Borland ML, et al. Efficacy of Prednisolone for Bell Palsy in Children: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Neurology 2022; 99:e2241.</a></li><li><a class="nounderline abstract_t">Yoo HW, Yoon L, Kim HY, et al. Comparison of conservative therapy and steroid therapy for Bell's palsy in children. Korean J Pediatr 2018; 61:332.</a></li><li><a class="nounderline abstract_t">Gagyor I, Madhok VB, Daly F, Sullivan F. Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2019; 9:CD001869.</a></li><li><a class="nounderline abstract_t">Gantz BJ, Rubinstein JT, Gidley P, Woodworth GG. Surgical management of Bell's palsy. Laryngoscope 1999; 109:1177.</a></li><li><a class="nounderline abstract_t">Berania I, Awad M, Saliba I, et al. Delayed facial nerve decompression for severe refractory cases of Bell's palsy: a 25-year experience. J Otolaryngol Head Neck Surg 2018; 47:1.</a></li><li><a class="nounderline abstract_t">Kim SH, Jung J, Lee JH, et al. Delayed facial nerve decompression for Bell's palsy. Eur Arch Otorhinolaryngol 2016; 273:1755.</a></li><li><a class="nounderline abstract_t">Li Y, Li Z, Yan C, Hui L. The effect of total facial nerve decompression in preventing further recurrence of idiopathic recurrent facial palsy. Eur Arch Otorhinolaryngol 2015; 272:1087.</a></li><li><a class="nounderline abstract_t">Grogan PM, Gronseth GS. Practice parameter: Steroids, acyclovir, and surgery for Bell's palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56:830.</a></li><li><a class="nounderline abstract_t">Baugh RF, Basura GJ, Ishii LE, et al. Clinical practice guideline: Bell's Palsy executive summary. Otolaryngol Head Neck Surg 2013; 149:656.</a></li><li><a class="nounderline abstract_t">Alam D. Advances in surgical treatment of facial nerve paralysis in children. JAMA 2011; 305:2106.</a></li><li><a class="nounderline abstract_t">Barr JS, Katz KA, Hazen A. Surgical management of facial nerve paralysis in the pediatric population. J Pediatr Surg 2011; 46:2168.</a></li><li><a class="nounderline abstract_t">Hadlock TA, Malo JS, Cheney ML, Henstrom DK. Free gracilis transfer for smile in children: the Massachusetts Eye and Ear Infirmary Experience in excursion and quality-of-life changes. Arch Facial Plast Surg 2011; 13:190.</a></li><li><a class="nounderline abstract_t">Brandt MG, Franklin JH, Moore CC. Direct nasolabial lift, a technique for palliation of oncologic lower-face paralysis. J Otolaryngol Head Neck Surg 2010; 39:476.</a></li><li><a class="nounderline abstract_t">Alam D. Rehabilitation of long-standing facial nerve paralysis with percutaneous suture-based slings. Arch Facial Plast Surg 2007; 9:205.</a></li><li><a class="nounderline abstract_t">Boahene KD, Farrag TY, Ishii L, Byrne PJ. Minimally invasive temporalis tendon transposition. Arch Facial Plast Surg 2011; 13:8.</a></li><li><a class="nounderline abstract_t">Peitersen E. Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 2002; :4.</a></li><li><a class="nounderline abstract_t">Chen WX, Wong V. Prognosis of Bell's palsy in children--analysis of 29 cases. Brain Dev 2005; 27:504.</a></li><li><a class="nounderline abstract_t">Hanci F, Türay S, Bayraktar Z, Kabakuş N. Childhood Facial Palsy: Etiologic Factors and Clinical Findings, an Observational Retrospective Study. J Child Neurol 2019; 34:907.</a></li><li><a class="nounderline abstract_t">Jenke AC, Stoek LM, Zilbauer M, et al. Facial palsy: etiology, outcome and management in children. Eur J Paediatr Neurol 2011; 15:209.</a></li><li><a class="nounderline abstract_t">Lee Y, SooYoon H, Yeo SG, Lee EH. Factors Associated With Fast Recovery of Bell Palsy in Children. J Child Neurol 2020; 35:71.</a></li><li class="breakAll">Sunderland S. Nerve and Nerve Injuries, 2nd ed, Churchill Livingstone, London 1978.</li><li><a class="nounderline abstract_t">House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg 1985; 93:146.</a></li><li><a class="nounderline abstract_t">Huang B, Zhou ZL, Wang LL, et al. Electrical response grading versus House-Brackmann scale for evaluation of facial nerve injury after Bell's palsy: a comparative study. J Integr Med 2014; 12:367.</a></li><li><a class="nounderline abstract_t">Khedr EM, Abo El-Fetoh N, El-Hammady DH, et al. Prognostic role of neurophysiological testing 3-7 days after onset of acute unilateral Bell's palsy. Neurophysiol Clin 2018; 48:111.</a></li><li><a class="nounderline abstract_t">May M, Klein SR, Taylor FH. Indications for surgery for Bell's palsy. Am J Otol 1984; 5:503.</a></li><li class="breakAll">Esslen E. Investigations on the localization and pathogenesis of meato-labyrinthine facial palsies. In: The Acute Facial Palsies, Esslen E (Ed), Springer-Verlag, Berlin 1977. p.41.</li><li><a class="nounderline abstract_t">Hughes GB. Practical management of Bell's palsy. Otolaryngol Head Neck Surg 1990; 102:658.</a></li><li><a class="nounderline abstract_t">Jabor MA, Gianoli G. Management of Bell's palsy. J La State Med Soc 1996; 148:279.</a></li><li><a class="nounderline abstract_t">Hashisaki GT. Medical management of Bell's palsy. Compr Ther 1997; 23:715.</a></li><li><a class="nounderline abstract_t">Husseman J, Mehta RP. Management of synkinesis. Facial Plast Surg 2008; 24:242.</a></li><li><a class="nounderline abstract_t">Psillas G, Antoniades E, Ieridou F, Constantinidis J. Facial nerve palsy in children: A retrospective study of 124 cases. J Paediatr Child Health 2019; 55:299.</a></li><li><a class="nounderline abstract_t">Eidlitz-Markus T, Gilai A, Mimouni M, Shuper A. Recurrent facial nerve palsy in paediatric patients. Eur J Pediatr 2001; 160:659.</a></li><li><a class="nounderline abstract_t">Sun B, Zhou C, Han Z. Facial palsy in Melkersson-Rosenthal syndrome and Bell's palsy: familial history and recurrence tendency. Ann Otol Rhinol Laryngol 2015; 124:107.</a></li><li><a class="nounderline abstract_t">Wang J, Li P, Jin X, et al. Outcomes of recurrent facial palsy in Melkersson Rosenthal syndrome. Ann Otol Rhinol Laryngol 2015; 124:232.</a></li><li><a class="nounderline abstract_t">Dai C, Li J, Yang S, et al. Subtotal facial nerve decompression for recurrent facial palsy in Melkersson Rosenthal syndrome. Acta Otolaryngol 2014; 134:425.</a></li><li><a class="nounderline abstract_t">Lloyd AV, Jewitt DE, Still JD. Facial paralysis in children with hypertension. Arch Dis Child 1966; 41:292.</a></li></ol></div><div id="topicVersionRevision">Topic 6217 Version 34.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9885321" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Peripheral facial palsy: etiology, diagnosis and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9747191" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The temporal bone. Contemporary diagnostic dilemmas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9747191" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The temporal bone. Contemporary diagnostic dilemmas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20139107" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Facial nerve palsy in the pediatric population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29427137" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Childhood peripheral facial palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9927969" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The facial nerve. Current trends in diagnosis, treatment, and rehabilitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8676313" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : All that palsies is not Bell's.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18360300" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Association between herpes simplex virus-1 infection and idiopathic unilateral facial paralysis in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/168802" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Idiopathic facial paralysis, pregnancy, and the menstrual cycle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36508882" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Association of Overweight and Obesity With Bell Palsy in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9282248" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Lyme disease and seventh nerve paralysis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2085110" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Peripheral facial palsy in childhood--Lyme borreliosis to be suspected unless proven otherwise.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24326802" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Facial nerve palsy: analysis of cases reported in children in a suburban hospital in Nigeria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8872479" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Localization of a gene for Möbius syndrome to chromosome 3q by linkage analysis in a Dutch family.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15728286" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The neuropathology of hereditary congenital facial palsy vs Möbius syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10441582" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : A second gene for autosomal dominant Möbius syndrome is localized to chromosome 10q, in a Dutch family.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22837071" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Congenital unilateral facial nerve palsy as an unusual presentation of BOR syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17572338" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Congenital cranial dysinnervation disorders and more.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12913192" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Möbius syndrome redefined: a syndrome of rhombencephalic maldevelopment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16801658" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The localization of facial motor impairment in sporadic Möbius syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28538051" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Mobius Syndrome: A 35-Year Single Institution Experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5474758" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Möbius syndrome in twins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24612975" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Diagnostic distinctions and genetic analysis of patients diagnosed with moebius syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1870098" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Deletion of chromosome 13 in Moebius syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1870098" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Deletion of chromosome 13 in Moebius syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23657208" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Microbiologic findings in acute facial palsy in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7503479" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Herpes simplex virus and Bell palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9393551" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Bell's palsy and herpes simplex virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7503474" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15702035" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Varicella-zoster virus reactivation is an important cause of acute peripheral facial paralysis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6097060" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Tick-borne meningopolyneuritis (Garin-Bujadoux, Bannwarth).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3966001" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4058212" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Facial paralysis in Lyme disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8811167" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Lyme neuroborreliosis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9093686" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Facial nerve palsy in Lyme disease: evaluation of clinical diagnostic criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2508822" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Lyme disease facial palsy: differentiation from Bell's palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9412598" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Cerebrospinal fluid findings in children with Lyme disease-associated facial nerve palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9412591" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Lyme disease and facial nerve palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1805637" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Association of facial paralysis with HIV positivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1315161" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Facial palsy and infection: the unfolding story.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32932336" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Peripheral Facial Nerve Palsy in Children With Enterovirus Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11420202" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Facial nerve palsy associated with Rickettsia conorii infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33824691" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : COVID-19 as a rare cause of facial nerve neuritis in a pediatric patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6743105" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Melkersson-Rosenthal syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3687163" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : [Classification and scope of clinical variations of Melkersson-Rosenthal syndrome].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1564749" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Bilateral facial paralysis: a case presentation and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23382485" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Peripheral facial nerve palsy in severe systemic hypertension: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32788067" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Risk of Leukemia in Children With Peripheral Facial Palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12160979" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Facial palsy, an unusual presenting feature of childhood leukemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34992025" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Risk of malignancy following emergency department Bell's palsy diagnosis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/495080" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Congenital unilateral lower lip palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15287415" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : A review of 35 cases of asymmetric crying facies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24137031" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Asymmetric crying facies in the 22q11.2 deletion syndrome: implications for future screening.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8584391" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Congenital unilateral facial paralysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17410591" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Electrodiagnostic studies of the facial nerve in peripheral facial palsy and hemifacial spasm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8797561" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Time course of Bell palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8426509" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Histologic correlation of the degenerating facial nerve with electroneurography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8246650" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Idiopathic facial nerve paralysis: a randomized double blind controlled study of placebo versus prednisone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7561508" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Early diagnosis and treatment of Ramsay Hunt syndrome: the role of magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31372902" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Infectious causes of peripheral facial nerve palsy in children-a retrospective cohort study with long-term follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33417672" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17522387" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23136264" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Evidence-based guideline update: steroids and antivirals for Bell palsy: report of the Guideline Development Subcommittee of the American Academy of Neurology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31390913" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Prognostic Factors Associated With Recovery in Children With Bell's Palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27686096" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Efficacy of Low-Dose Corticosteroid Therapy Versus High-Dose Corticosteroid Therapy in Bell's Palsy in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19724046" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19736282" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : The benefits of steroids versus steroids plus antivirals for treatment of Bell's palsy: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22217913" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : A small effect of adding antiviral agents in treating patients with severe Bell palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20238317" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Corticosteroids for Bell's palsy (idiopathic facial paralysis).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25554380" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Antiviral treatment of Bell's palsy based on baseline severity: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8651631" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Bell's palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : [Clinical treatment of Bell's palsy: comparative study among valaciclovir plus deflazacort, deflazacort and placebo]</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17202945" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17414047" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17942873" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Early treatment with prednisolone or acyclovir in Bell's palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18439948" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Acyclovir plus steroid vs steroid alone in the treatment of Bell's palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18849193" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22503409" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Do children with Bell's palsy benefit from steroid treatment? A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10593672" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Corticosteroid treatment of childhood Bell's palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36008143" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Efficacy of Prednisolone for Bell Palsy in Children: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30304913" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Comparison of conservative therapy and steroid therapy for Bell's palsy in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31486071" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Antiviral treatment for Bell's palsy (idiopathic facial paralysis).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10443817" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Surgical management of Bell's palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29301560" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Delayed facial nerve decompression for severe refractory cases of Bell's palsy: a 25-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26319412" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Delayed facial nerve decompression for Bell's palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24493560" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : The effect of total facial nerve decompression in preventing further recurrence of idiopathic recurrent facial palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11294918" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Practice parameter: Steroids, acyclovir, and surgery for Bell's palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24190889" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Clinical practice guideline: Bell's Palsy executive summary.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21614803" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Advances in surgical treatment of facial nerve paralysis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22075352" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Surgical management of facial nerve paralysis in the pediatric population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21576665" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Free gracilis transfer for smile in children: the Massachusetts Eye and Ear Infirmary Experience in excursion and quality-of-life changes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20643020" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Direct nasolabial lift, a technique for palliation of oncologic lower-face paralysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17515497" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Rehabilitation of long-standing facial nerve paralysis with percutaneous suture-based slings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21242425" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Minimally invasive temporalis tendon transposition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12482166" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16198208" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Prognosis of Bell's palsy in children--analysis of 29 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31407620" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Childhood Facial Palsy: Etiologic Factors and Clinical Findings, an Observational Retrospective Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21159531" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Facial palsy: etiology, outcome and management in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31623512" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Factors Associated With Fast Recovery of Bell Palsy in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31623512" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Factors Associated With Fast Recovery of Bell Palsy in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3921901" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Facial nerve grading system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25074886" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Electrical response grading versus House-Brackmann scale for evaluation of facial nerve injury after Bell's palsy: a comparative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29496378" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Prognostic role of neurophysiological testing 3-7 days after onset of acute unilateral Bell's palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6517138" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Indications for surgery for Bell's palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6517138" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Indications for surgery for Bell's palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2115651" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Practical management of Bell's palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8816019" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Management of Bell's palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9360798" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Medical management of Bell's palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18470836" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Management of synkinesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30144181" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Facial nerve palsy in children: A retrospective study of 124 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11760022" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Recurrent facial nerve palsy in paediatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25124841" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Facial palsy in Melkersson-Rosenthal syndrome and Bell's palsy: familial history and recurrence tendency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25385841" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Outcomes of recurrent facial palsy in Melkersson Rosenthal syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24512460" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Subtotal facial nerve decompression for recurrent facial palsy in Melkersson Rosenthal syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5940617" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Facial paralysis in children with hypertension.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
